{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:37:17Z","timestamp":1777912637147,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.14283\/jpad.2023.36","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T06:54:45Z","timestamp":1680245685000},"page":"536-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Genetic Validation of the Neurodegeneration Biomarkers Tau-A and Tau-C - A Mendelian Randomization Study"],"prefix":"10.1016","volume":"10","author":[{"given":"T.M.","family":"Axelsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bihlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.E.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2023.36_bib1","article-title":"World Alzheimer report 2018","author":"Patterson","year":"2018","journal-title":"Alzheimer's Disease International"},{"key":"10.14283\/jpad.2023.36_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"issue":"6","key":"10.14283\/jpad.2023.36_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer's disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J Intern Med"},{"issue":"8","key":"10.14283\/jpad.2023.36_bib4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.14283\/jpad.2023.36_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","article-title":"Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative","volume":"26","author":"Karikari","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.14283\/jpad.2023.36_bib6","doi-asserted-by":"crossref","first-page":"e0194802","DOI":"10.1371\/journal.pone.0194802","article-title":"Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study","volume":"13","author":"Neergaard","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.14283\/jpad.2023.36_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-140984","article-title":"Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease","volume":"43","author":"Henriksen","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.14283\/jpad.2023.36_bib8","doi-asserted-by":"crossref","first-page":"e64990","DOI":"10.1371\/journal.pone.0064990","article-title":"An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function","volume":"8","author":"Henriksen","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.14283\/jpad.2023.36_bib9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2174\/1570159X18666200525020259","article-title":"The Role of Mitochondrial Impairment in Alzheimer's Disease Neurodegeneration: The Tau Connection","volume":"18","author":"Quntanilla","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"7292","key":"10.14283\/jpad.2023.36_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature08890","article-title":"Caspase activation precedes and leads to tangles","volume":"464","author":"de Calignon","year":"2010","journal-title":"Nature"},{"issue":"0 SE-Reviews","key":"10.14283\/jpad.2023.36_bib11","article-title":"Neuropathology of the Alzheimer's continuum: an update","volume":"1","author":"Jellinger","year":"2020","journal-title":"Free Neuropathol [Internet]"},{"issue":"2","key":"10.14283\/jpad.2023.36_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s12035-017-0385-x","article-title":"Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease","volume":"55","author":"P\u00e9rez","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.14283\/jpad.2023.36_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnmol.2017.00056","article-title":"Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms","volume":"10","author":"Endres","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.14283\/jpad.2023.36_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-020-00750-y","article-title":"ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study","volume":"13","author":"Oliveira Monteiro","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.14283\/jpad.2023.36_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"issue":"8","key":"10.14283\/jpad.2023.36_bib16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J Neurol"},{"issue":"1","key":"10.14283\/jpad.2023.36_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41531-021-00200-y","article-title":"TOMM40 \u201c523\u201d poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson's disease","volume":"7","author":"Bakeberg","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.14283\/jpad.2023.36_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"6420","key":"10.14283\/jpad.2023.36_bib19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.aau0437","article-title":"Alzheimer's disease: The right drug, the right time","volume":"362","author":"Golde","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.14283\/jpad.2023.36_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","article-title":"GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease","volume":"78","author":"Cruchaga","year":"2013","journal-title":"Neuron"},{"issue":"7","key":"10.14283\/jpad.2023.36_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.0000000000003615","article-title":"Genome-wide association study identifies MAPT locus influencing human plasma tau levels","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.14283\/jpad.2023.36_bib22","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1212\/NXG.0000000000000508","article-title":"Matrix metalloproteinase-degraded type I collagen is associated with <em>APOE\/TOMM40<\/em> variants and preclinical dementia","volume":"6","author":"Tang","year":"2020","journal-title":"Neurol Genet [Internet]"},{"issue":"4","key":"10.14283\/jpad.2023.36_bib23","first-page":"1104","article-title":"Cohort Profile: The Prospective Epidemiological Risk Factor (PERF) study","volume":"46","author":"Neergaard","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.14283\/jpad.2023.36_bib24","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"10.14283\/jpad.2023.36_bib25","volume":"4","year":"2015","journal-title":"Gigascience"},{"issue":"8","key":"10.14283\/jpad.2023.36_bib26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"issue":"12","key":"10.14283\/jpad.2023.36_bib27","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1371\/journal.pgen.0020190","article-title":"Population structure and eigenanalysis","volume":"2","author":"Patterson","year":"2006","journal-title":"PLoS Genet"},{"key":"10.14283\/jpad.2023.36_bib28","author":"Turner"},{"issue":"1","key":"10.14283\/jpad.2023.36_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-02317-2","article-title":"Causal associations between risk factors and common diseases inferred from GWAS summary data","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.14283\/jpad.2023.36_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","article-title":"Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes","volume":"53","author":"Schwartzentruber","year":"2021","journal-title":"Nat Genet"},{"issue":"8","key":"10.14283\/jpad.2023.36_bib31","doi-asserted-by":"crossref","first-page":"e6501","DOI":"10.1371\/journal.pone.0006501","article-title":"Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease","volume":"4","author":"Potkin","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.14283\/jpad.2023.36_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/hmg\/3.4.569","article-title":"Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region","volume":"3","author":"Chartier-Harlin","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.14283\/jpad.2023.36_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"issue":"2","key":"10.14283\/jpad.2023.36_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/WCO.0000000000000904","article-title":"Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"34","author":"Leuzy","year":"2021","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.14283\/jpad.2023.36_bib35","doi-asserted-by":"crossref","first-page":"e64990","DOI":"10.1371\/journal.pone.0064990","article-title":"An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function","volume":"8","author":"Henriksen","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.14283\/jpad.2023.36_bib36","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awaa054","article-title":"Plasma tau, neurofilament light chain and amyloid-\u03b2 levels and risk of dementia; a population-based cohort study","volume":"143","author":"de Wolf","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.14283\/jpad.2023.36_bib37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurol"},{"issue":"17","key":"10.14283\/jpad.2023.36_bib38","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.14283\/jpad.2023.36_bib39","doi-asserted-by":"crossref","first-page":"101699","DOI":"10.1016\/j.arr.2022.101699","article-title":"Prospective biomarkers of Alzheimer's disease: A systematic review and meta-analysis","volume":"81","author":"Li","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.14283\/jpad.2023.36_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.14283\/jpad.2023.36_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero Rodriguez","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"22","key":"10.14283\/jpad.2023.36_bib42","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1089\/neu.2014.3741","article-title":"Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players","volume":"33","author":"Shahim","year":"2016","journal-title":"J Neurotrauma"},{"issue":"6","key":"10.14283\/jpad.2023.36_bib43","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/1354750X.2019.1609580","article-title":"Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest","volume":"24","author":"Grand","year":"2019","journal-title":"Biomarkers"},{"issue":"1","key":"10.14283\/jpad.2023.36_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J Clin Invest"},{"issue":"6","key":"10.14283\/jpad.2023.36_bib45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1176\/ajp.140.6.734","article-title":"Validation of a short Orientation-Memory-Concentration Test of cognitive impairment","volume":"140","author":"Katzman","year":"1983","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.14283\/jpad.2023.36_bib46","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","article-title":"Alzheimer's pathogenic mechanisms and underlying sex difference","volume":"78","author":"Zhu","year":"2021","journal-title":"Cell Mol Life Sci [Internet]"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:39:47Z","timestamp":1736469587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2274580724002139"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.36","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Genetic Validation of the Neurodegeneration Biomarkers Tau-A and Tau-C - A Mendelian Randomization Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.36","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}